{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T09:00:02Z","timestamp":1764061202156},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,31]]},"DOI":"10.7759\/cureus.48080","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T05:39:25Z","timestamp":1698817165000},"source":"Crossref","is-referenced-by-count":1,"title":["Procalcitonin Use for Predicting Mortality and Morbidity of Patients Diagnosed With Sepsis Within the Intensive Care Unit"],"prefix":"10.7759","author":[{"given":"Christopher R","family":"Chew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhaval","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ania I","family":"Rynarzewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/cc6860","article-title":"Pro\/Con debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients?","volume":"12","author":"Shehabi Y","year":"2008","unstructured":"Shehabi Y, Seppelt I. Pro\/Con debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients?. Crit Care. 2008, 12:211. 10.1186\/cc6860","journal-title":"Crit Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802670","article-title":"Procalcitonin-guided use of antibiotics for lower respiratory tract infection","volume":"379","author":"Huang DT","year":"2018","unstructured":"Huang DT, Yealy DM, Filbin MR, et al.. Procalcitonin-guided use of antibiotics for lower respiratory tract infection. N Engl J Med. 2018, 379:236-49. 10.1056\/NEJMoa1802670","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2018-1181","article-title":"Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use","volume":"57","author":"Schuetz P","year":"2019","unstructured":"Schuetz P, Beishuizen A, Broyles M, et al.. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med. 2019, 57:1308-18. 10.1515\/cclm-2018-1181","journal-title":"Clin Chem Lab Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201408-1483OC","article-title":"Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial","volume":"190","author":"Shehabi Y","year":"2014","unstructured":"Shehabi Y, Sterba M, Garrett PM, et al.. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial. Am J Respir Crit Care Med. 2014, 190:1102-10. 10.1164\/rccm.201408-1483OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"PRORATA trial group. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"6","author":"Bouadma L","year":"2010","unstructured":"Bouadma L, Luyt CE, Tubach F, et. al.. PRORATA trial group. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010, 6:463-74. 10.1016\/S0140-6736(09)61879-1","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.86a.18074","article-title":"Can procalcitonin guide decisions about antibiotic management?","volume":"86","author":"Fakheri RJ","year":"2019","unstructured":"Fakheri RJ. Can procalcitonin guide decisions about antibiotic management?. Cleve Clin J Med. 2019, 86:307-11. 10.3949\/ccjm.86a.18074","journal-title":"Cleve Clin J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-178","article-title":"Stop antibiotics on guidance of procalcitonin study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients - calculated sample size: 1816 patients","volume":"13","author":"Assink-de Jong E","year":"2013","unstructured":"Assink-de Jong E, de Lange DW, van Oers JA, Nijsten MW, Twisk JW, Beishuizen A. Stop antibiotics on guidance of procalcitonin study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients - calculated sample size: 1816 patients. BMC Infect Dis. 2013, 13:178. 10.1186\/1471-2334-13-178","journal-title":"BMC Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-018-0415-5","article-title":"Adherence to a procalcitonin-guided antibiotic treatment protocol in patients with severe sepsis and septic shock","volume":"8","author":"Hohn A","year":"2018","unstructured":"Hohn A, Balfer N, Heising B, Hertel S, Wiemer JC, Hochreiter M, Schr\u00f6der S. Adherence to a procalcitonin-guided antibiotic treatment protocol in patients with severe sepsis and septic shock. Ann Intensive Care. 2018, 8:68. 10.1186\/s13613-018-0415-5","journal-title":"Ann Intensive Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2125-7","article-title":"Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials","volume":"22","author":"Wirz Y","year":"2018","unstructured":"Wirz Y, Meier MA, Bouadma L, et al.. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials. Crit Care. 2018, 22:191. 10.1186\/s13054-018-2125-7","journal-title":"Crit Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-017-0246-8","article-title":"Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy","volume":"5","author":"Vijayan AL","year":"2017","unstructured":"Vijayan AL, Vanimaya, Ravindran S, Saikant R, Lakshmi S, Kartik R, G M. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017, 5:51. 10.1186\/s40560-017-0246-8","journal-title":"J Intensive Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"Schuetz P","year":"2018","unstructured":"Schuetz P, Wirz Y, Sager R, et al.. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018, 18:95-107. 10.1016\/S1473-3099(17)30592-3","journal-title":"Lancet Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.11.63","article-title":"Role of procalcitonin use in the management of sepsis","volume":"12","author":"Gregoriano C","year":"2020","unstructured":"Gregoriano C, Heilmann E, Molitor A, Schuetz P. Role of procalcitonin use in the management of sepsis. J Thorac Dis. 2020, 12:S5-S15. 10.21037\/jtd.2019.11.63","journal-title":"J Thorac Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy313","article-title":"Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit","volume":"5","author":"Sakr Y","year":"2018","unstructured":"Sakr Y, Jaschinski U, Wittebole X, et al.. Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open Forum Infect Dis. 2018, 5:ofy313. 10.1093\/ofid\/ofy313","journal-title":"Open Forum Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mpaic.2012.11.010","article-title":"Recognizing the critically ill patient","volume":"14","author":"Robertson LC","year":"2017","unstructured":"Robertson LC, Al-Haddad M. Recognizing the critically ill patient. Anaesth Intensive Care. 2017, 14:11-4. 10.1016\/j.mpaic.2012.11.010","journal-title":"Anaesth Intensive Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002321","article-title":"Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin monitoring sepsis (moses) study","volume":"45","author":"Schuetz P","year":"2017","unstructured":"Schuetz P, Birkhahn R, Sherwin R, et al.. Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin monitoring sepsis (moses) study. Crit Care Med. 2017, 45:781-9. 10.1097\/CCM.0000000000002321","journal-title":"Crit Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/197399-procalcitonin-use-for-predicting-mortality-and-morbidity-of-patients-diagnosed-with-sepsis-within-the-intensive-care-unit","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:26Z","timestamp":1707509366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/197399-procalcitonin-use-for-predicting-mortality-and-morbidity-of-patients-diagnosed-with-sepsis-within-the-intensive-care-unit"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.48080","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,31]]}}}